Eli Lilly and Company is a pharmaceutical company based in Indianapolis in the United States. It researches, develops and manufactures prescription medicines for people with conditions such as diabetes, obesity, cancer, immune disorders and mental health problems. Its products include insulin treatments and other branded drugs, and it supplies them to hospitals, doctors, pharmacies and patients in many countries around the world through wholesale and distribution channels.
The shares are listed on the SIX Swiss Exchange in Switzerland under the code LLY, and the price on this page is in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #94 of 225 on the SIX Swiss Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Switzerland yet.
TrendStrong
90/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average24.3%
From 52-week high0.0%
MomentumStrong
87/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return13.8%
6-month return51.5%
12-month, skipping last month51.8%
Stability (higher is calmer)Weak
38/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)39.6%
Worst drawdown, 1 year (smaller is calmer)-24.3%
LiquidityWeak
3/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.00M CHF
Zero-volume days78.3%
IncomeWeak
30/100
Dividend is small or irregular.
See the numbers →
Dividend yield0.4%
Years with dividends6
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Switzerland when fundamentals data for this market is added. All Switzerland stocks.
52-wk range 640.00 – 1,080.00Daily closes, split-adjusted
Signals
50-day average974.77
200-day average869.14
Golden/death cross (60d)None
New 52-week highYes
Bullish RSI divergenceNo
Average daily range (ATR)39.96
Technical summary
Daily
Strongly bullish
12 bullish · 1 neutral · 3 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
1,017.5
Bullish
EMA 10
1,029.6
Bullish
SMA 20
995.5
Bullish
EMA 20
1,005.2
Bullish
SMA 50
974.8
Bullish
EMA 50
977.0
Bullish
SMA 100
956.8
Bullish
EMA 100
942.7
Bullish
SMA 200
869.1
Bullish
EMA 200
885.0
Bullish
Oscillators (daily)
RSI (14)
69.36
Neutral
MACD (12, 26)
26.22
Bullish
Momentum (12)
13.09
Bullish
Stochastic %K (14)
100.0
Bearish
Williams %R (14)
0.00
Bearish
CCI (20)
141.5
Bearish
Pivot points (classic, last session)
S3
871.7
S2
913.3
S1
996.7
Pivot
1,038.3
R1
1,121.7
R2
1,163.3
R3
1,246.7
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
5.28 USD
Yield on today's price
0.40%
Frequency
Quarterly
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
1.4038
1.3538
1.3324
1.1901
1.2079
1.2588
1.3468
1.1543
1.1324
1.1763
1.1523
1.0081
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in CHF. Educational only, not financial advice.
